CD274 and gastric cancer: Of note, authors highlighted no difference regarding familiarity with GC, HER2, or MSI-H expression between the two groups of patients but a significant positive association between PD-L1 immunostaining with EBVaGC (50% of cases) and the good clinical prognosis.